The company’s shares were admitted to dealings on the NSE with effect from *Monday, August 17, 2026, under the symbol BLUECLOUDS. The company continues to be listed on the BSE under scrip code 539607.
92.31 Crore Shares Admitted to NSE
A total of 92,30,81,600 equity shares with a face value of ₹1 each have been admitted for trading on the NSE Main Board. The securities have been admitted under the permitted-to-trade category for companies that are already listed on another recognised stock exchange.
According to the company, the NSE admission is expected to widen access to its shares among retail and institutional investors, deepen liquidity and support the creation of a broader and more diversified shareholder base. The company also stated that the dual listing does not involve any change in its share capital, shareholding or business operations.
AI and Digital Infrastructure Expansion
Blue Cloud Softech describes itself as an AI-first technology company with operations spanning public safety, healthcare, telecom and 5G digital infrastructure, and enterprise IT services.
Its technology portfolio includes sovereign AI platforms such as Blura SAGA and SOCEYE for public safety, BluHealth for healthcare and Praptham for telecom and 5G digital infrastructure. The company is also expanding its presence across India, the United States and Africa.
The company said its Africa expansion is being pursued through strategic partnerships, including projects and initiatives in Ghana, Liberia and Senegal. These include digital infrastructure, AI-enabled mining surveillance and healthcare digitalisation initiatives.
FY26 Revenue Crosses ₹1,000 Crore
The NSE listing comes against the backdrop of strong reported financial growth.
For FY26, Blue Cloud Softech reported consolidated revenue of ₹1,002 crore, representing a 26% year-on-year increase. EBITDA stood at ₹126.13 crore, up 78%, while profit after tax rose 37% to ₹60.50 crore. The company reported FY26 EPS of ₹1.13.
The growth continued into the first quarter of FY27. Consolidated revenue increased 41.9% year-on-year to ₹292.53 crore, while EBITDA rose to ₹59.61 crore, compared with ₹10.4% EBITDA margin a year earlier. Q1 FY27 profit after tax stood at ₹17.95 crore, up 24.7% year-on-year.
Company Sees NSE Listing as Capital-Market Milestone
The company said its market capitalisation had remained above the NSE’s stated eligibility threshold of ₹1,500 crore on a six-month average basis, alongside a clean compliance and investor-grievance record. The Board had approved the NSE listing initiative on April 30, 2026.
According to Blue Cloud Softech, access to the NSE’s institutional and retail investor base could strengthen its capital-market foundation as it pursues expansion in AI platforms, government contracts and digital infrastructure.
The company has positioned the dual listing as a step towards increasing investor choice and liquidity while supporting its longer-term expansion across India, the US and Africa.
Investor Takeaway
The NSE admission gives Blue Cloud Softech investors access to the company’s shares on both of India’s principal stock exchanges. The development comes at a time when the company is reporting strong revenue and EBITDA growth and expanding its AI-led technology and digital infrastructure businesses.
For investors tracking BLUECLOUDS, the key factors to monitor going forward will include the company’s ability to sustain its recent growth rates, convert its international opportunities into executable projects, maintain margins and scale its sovereign AI platforms across its target markets.
Company: Blue Cloud Softech Solutions Limited
NSE Symbol: BLUECLOUDS
BSE Scrip Code: 539607
ISIN: INE373T01047
NSE Trading Commencement: August 17, 2026
Shares Admitted: 92.31 crore
FY26 Revenue: ₹1,002 crore
FY26 EBITDA: ₹126.13 crore
FY26 PAT: ₹60.50 crore
Q1 FY27 Revenue: ₹292.53 crore
Q1 FY27 PAT: ₹17.95 crore
Source: Company regulatory filing and press release dated August 18, 2026.
Disclaimer: This article is for informational purposes only and does not constitute financial advice.
